PGP and glioma: Gerstner et al. reported that immunochemical P-gp expression in the neovasculature of metastatic brain tumors was less than that of gliomas and suggested that metastatic brain tumors with low P-gp expression might be more permeable to natural product chemotherapy drugs than gliomas [21].